Document is current
Any future updates will be listed below
-
Authors
Park, Ji Hyeun
Kim, Hyun Sook
Choi, Seong Hye
Jeong, Jee Hyang
Moon, So Young
Park, Yoo Kyoung
Hong, Chang Hyung
Cho, Soo Hyun
Na, Hae Ri
Kim, Hang-Rai
-
Funding
Funding for this research was provided by:
National Research Council of Science and Technology (CRC22013-600)
Institute of Information and Communications Technology Planning and Evaluation (2022-0-00448 / RS-2022-II220448)
Korea Dementia Research Center (RS-2021-KH112062)
- License Information
-
More Information
Article History
Received: 19 June 2025
Accepted: 20 January 2026
First Online: 30 January 2026
Declarations
:
: H.R.K and J.H.P. are employees of Rowan Inc. but were not involved in the original SUPERBRAIN-MEET trial; their role in the present study was limited to secondary data analysis. S.H.C., J.H.J., S.Y.M., Y.K.P., C.H.H., and H.R.N. were investigators in the original trial and are shareholders of Rowan Inc. All clinical assessments and data collection were conducted independently by investigators at the participating hospitals. Employees of Rowan Inc. were not involved in participant recruitment, clinical assessments, data management, or outcome evaluation. J.H.J. and S.H.C. have served as consultants for PeopleBio Co. Ltd. C.H.H. has received research funding from Eisai Korea Inc., and S.H.C. is the head of Exercowork. The remaining authors declare no competing interests.
